(MFC) Manulife Financial - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA56501R1064
MFC: Insurance, Annuities, Investments, Banking, Assets, Management
Manulife Financial Corporation, a global leader in financial services, operates across the United States, Canada, Asia, and other international markets. Established in 1887 and headquartered in Toronto, Canada, the company is structured into three primary segments: Wealth and Asset Management Businesses, Insurance and Annuity Products, and Corporate and Other.
The Wealth and Asset Management Businesses segment offers investment advice and solutions tailored to retirement, retail, and institutional clients. Utilizing diverse distribution channels, including affiliated agents, brokers, independent securities firms, pension plan consultants, and banks, the segment provides comprehensive investment advisory services and wealth management solutions.
The Insurance and Annuity Products segment specializes in individual life insurance, long-term care insurance, and annuity products, offering both guaranteed and partially guaranteed options. These products are distributed through multiple channels, including insurance agents, brokers, banks, financial planners, and direct marketing, addressing clients risk management and capital protection needs.
The Corporate and Other segment encompasses property and casualty reinsurance, run-off reinsurance operations, including variable annuities and accident and health insurance. Additionally, the company manages alternative investments such as timberland and agricultural portfolios, showcasing its strategic diversification and risk management approach.
Manulife also engages in various financial services, including insurance agency, investment counseling, mutual fund management, property and casualty insurance, and integrated banking products. This multifaceted approach underscores its commitment to providing a broad range of financial solutions.
As of the latest data, Manulife has a market capitalization of 76,323.58M CAD, with a P/E ratio of 15.63 and a forward P/E of 10.98. The price-to-book ratio stands at 1.76, and the price-to-sales ratio is 2.54, offering investors key valuation metrics for assessment.
For more information, visit their official website: https://www.manulife.com.
Additional Sources for MFC Stock
MFC Stock Overview
Market Cap in USD | 54,877m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception |
MFC Stock Ratings
Growth 5y | 82.7% |
Fundamental | 25.4% |
Dividend | 51.0% |
Rel. Strength Industry | 5.7 |
Analysts | - |
Fair Price Momentum | 42.04 CAD |
Fair Price DCF | 124.83 CAD |
MFC Dividends
Dividend Yield 12m | 2.88% |
Yield on Cost 5y | 6.00% |
Annual Growth 5y | 0.91% |
Payout Consistency | 72.9% |
MFC Growth Ratios
Growth Correlation 3m | -74.6% |
Growth Correlation 12m | 92.3% |
Growth Correlation 5y | 90.3% |
CAGR 5y | 17.23% |
CAGR/Max DD 5y | 0.38 |
Sharpe Ratio 12m | 1.47 |
Alpha | 19.51 |
Beta | 0.78 |
Volatility | 17.79% |
Current Volume | 6531.4k |
Average Volume 20d | 7687.1k |
As of February 23, 2025, the stock is trading at CAD 43.16 with a total of 6,531,393 shares traded.
Over the past week, the price has changed by +2.59%, over one month by -2.42%, over three months by -5.48% and over the past year by +37.45%.
Neither. Based on ValueRay Fundamental Analyses, Manulife Financial is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 25.36 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MFC as of February 2025 is 42.04. This means that MFC is currently overvalued and has a potential downside of -2.59%.
Manulife Financial has no consensus analysts rating.
According to ValueRays Forecast Model, MFC Manulife Financial will be worth about 50.4 in February 2026. The stock is currently trading at 43.16. This means that the stock has a potential upside of +16.77%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 48.4 | 12.2% |
Analysts Target Price | - | - |
ValueRay Target Price | 50.4 | 16.8% |